For metastatic prostate cancer, immunotherapy may have unexpected potential

byColumbia University Irving Medical CenterCredit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.10.006Immunotherapy has been disappointing as a prostate cancer treatment, but a new Co

Updated on: January 26,2024 21

For metastatic prostate cancer, immunotherapy may have unexpected potential

byColumbia University Irving Medical CenterCredit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.10.006Immunotherapy has been disappointing as a prostate cancer treatment, but a new Co

Updated on:January 26,2024 21

Prenatal exposure to anti-nausea drug in '60s, '70s tied to increased risk of colorectal cancer

byUniversity of Texas Health Science Center at HoustonCredit: Pixabay/CC0 Public DomainPrenatal exposure to an anti-nausea drug commonly used in the 1960s and 1970s has been shown to increase ri

Updated on: December 28,2023 10

Prenatal exposure to anti-nausea drug in '60s, '70s tied to increased risk of colorectal cancer

byUniversity of Texas Health Science Center at HoustonCredit: Pixabay/CC0 Public DomainPrenatal exposure to an anti-nausea drug commonly used in the 1960s and 1970s has been shown to increase ri

Updated on:December 28,2023 10

Chlorhexidine disinfectant may perform best in killing bone tumor cells after surgery

byWolters Kluwer HealthThe widely used disinfectant chlorhexidine gluconate (CHG) appears to be the most effective irrigation solution for use as part of the surgical treatment of bone tumors, s

Updated on: December 28,2023 8

Chlorhexidine disinfectant may perform best in killing bone tumor cells after surgery

byWolters Kluwer HealthThe widely used disinfectant chlorhexidine gluconate (CHG) appears to be the most effective irrigation solution for use as part of the surgical treatment of bone tumors, s

Updated on:December 28,2023 8

Engineered peptides open new avenue for immunotherapy drug development

by University of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainIn a new study published in Nature Biomedical Engineering, researchers at The University of Texas MD Anderson Cance

Updated on: May 14,2024 0

Engineered peptides open new avenue for immunotherapy drug development

by University of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainIn a new study published in Nature Biomedical Engineering, researchers at The University of Texas MD Anderson Cance

Updated on:May 14,2024 0

Could that breast pain be cancer? When to get a mammogram

byPennsylvania State UniversityCredit: Unsplash/CC0 Public DomainIf you've ever felt pain, tenderness and tightness—maybe even a sharp, stabbing sensation—in your breasts, it's hard not

Updated on: January 02,2024 9

Could that breast pain be cancer? When to get a mammogram

byPennsylvania State UniversityCredit: Unsplash/CC0 Public DomainIf you've ever felt pain, tenderness and tightness—maybe even a sharp, stabbing sensation—in your breasts, it's hard not

Updated on:January 02,2024 9

Exploring the role of reactive oxygen species in cellular health and disease through HyPerion

Updated on: July 17,2024 0

Exploring the role of reactive oxygen species in cellular health and disease through HyPerion

Updated on:July 17,2024 0

Study suggests the possibility of combination therapy of SORA and FGF21 in hepatocellular carcinoma

by Higher Education PressFGF21 combined with SORA promotes apoptosis and inhibits proliferation of 7721‐Smad3 cells under anaerobic conditions. Credit: Ting Zhang, Huiling Shi, Shihui Zhang, Qin Zhu,

Updated on: May 16,2024 7

Study suggests the possibility of combination therapy of SORA and FGF21 in hepatocellular carcinoma

by Higher Education PressFGF21 combined with SORA promotes apoptosis and inhibits proliferation of 7721‐Smad3 cells under anaerobic conditions. Credit: Ting Zhang, Huiling Shi, Shihui Zhang, Qin Zhu,

Updated on:May 16,2024 7

Research raises hope for new therapies for chordoma, a rare bone cancer

by Tom Ulrich,Broad Institute of MIT and HarvardCredit: Susanna M. Hamilton, Broad CommunicationsChordoma is literally a one in a million cancer, with few effective treatment options. A new unde

Updated on: May 31,2024 5

Research raises hope for new therapies for chordoma, a rare bone cancer

by Tom Ulrich,Broad Institute of MIT and HarvardCredit: Susanna M. Hamilton, Broad CommunicationsChordoma is literally a one in a million cancer, with few effective treatment options. A new unde

Updated on:May 31,2024 5

A new approach for bolstering the ability of T cells to fight cancer

by Monash UniversityCredit: CC0 Public DomainA collaborative study led by the Monash Biomedicine Discovery Institute (BDI) has discovered a new immune checkpoint that may be exploited for cancer

Updated on: March 25,2024 10

A new approach for bolstering the ability of T cells to fight cancer

by Monash UniversityCredit: CC0 Public DomainA collaborative study led by the Monash Biomedicine Discovery Institute (BDI) has discovered a new immune checkpoint that may be exploited for cancer

Updated on:March 25,2024 10

Immunotherapy after surgery found to provide significant, durable benefit for high-risk bladder patients

byThe Mount Sinai HospitalCredit: Unsplash/CC0 Public DomainImmunotherapy after surgery increased bladder cancer patients' chance of staying cancer-free compared to patients who received a p

Updated on: January 04,2024 10

Immunotherapy after surgery found to provide significant, durable benefit for high-risk bladder patients

byThe Mount Sinai HospitalCredit: Unsplash/CC0 Public DomainImmunotherapy after surgery increased bladder cancer patients' chance of staying cancer-free compared to patients who received a p

Updated on:January 04,2024 10

Targeted therapy extends survival in cancers of unknown primary

by Julia Bird, Universitätsklinikum HeidelbergProgression-free survival in the intention-to-treat population, category 1 patients. Credit:The Lancet(2024). DOI: 10.1016/S0140-6736(24)00814

Updated on: August 27,2024 0

Targeted therapy extends survival in cancers of unknown primary

by Julia Bird, Universitätsklinikum HeidelbergProgression-free survival in the intention-to-treat population, category 1 patients. Credit:The Lancet(2024). DOI: 10.1016/S0140-6736(24)00814

Updated on:August 27,2024 0

Hope for new therapy to stop advanced skin cancer

bySt. George's University of LondonMorphological effects of P16P1 observed for melanoma cells but not fibroblasts. Representative phase-contrast images of cells after 5 days of growth with o

Updated on: January 10,2024 10

Hope for new therapy to stop advanced skin cancer

bySt. George's University of LondonMorphological effects of P16P1 observed for melanoma cells but not fibroblasts. Representative phase-contrast images of cells after 5 days of growth with o

Updated on:January 10,2024 10